You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
盤龍藥業(002864.SZ):子公司擬收購陝西博華醫藥51%的股權
格隆匯 05-11 20:18

格隆匯5月11日丨盤龍藥業(002864.SZ)公佈,公司子公司醫藥股份於2020年5月9日與自然人張衞傑簽署了《股權轉讓框架協議》,醫藥股份擬通過股權受讓方式收購自然人張衞傑現持有的陝西博華醫藥有限公司(“標的公司”)51%的股權,此次交易完成後,標的公司將成為醫藥股份的控股子公司。

若此次交易能順利實施並完成後續工作,將進一步完善公司的“一體兩翼”佈局,擴大醫藥股份現有的配送網絡,提升其配送的體量和市場份額,實現雙方的協同效應。同時為公司輸入優秀的醫藥商業和醫藥零售人才隊伍。從而鞏固及深化公司現有的產業格局,提高公司的業務規模及盈利水平,對公司的可持續發展具有積極意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account